Q2 EPS Forecast for Xenon Pharmaceuticals Boosted by Analyst
Xenon Pharmaceuticals Inc. (NASDAQ:XENE – Free Report) – Analysts at HC Wainwright increased their Q2 2025 earnings per share (EPS) estimates for Xenon Pharmaceuticals in a report released on Tuesday, May 13th. HC Wainwright analyst D. Tsao now forecasts that the biopharmaceutical company will earn ($1.08) per share for the quarter, up from their prior […]
Xenon Pharmaceuticals Inc. (NASDAQ:XENE – Free Report) – Analysts at HC Wainwright increased their Q2 2025 earnings per share (EPS) estimates for Xenon Pharmaceuticals in a report released on Tuesday, May 13th. HC Wainwright analyst D. Tsao now forecasts that the biopharmaceutical company will earn ($1.08) per share for the quarter, up from their prior […]
